LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

Hologic Inc

Closed

SectorHealthcare

64.32 2.11

Overview

Share price change

24h

Current

Min

64.2

Max

64.57

Key metrics

By Trading Economics

Income

-218M

-17M

Sales

-17M

1B

P/E

Sector Avg

26.055

51.198

EPS

1.03

Profit margin

-1.731

Employees

7,063

EBITDA

-359M

-7M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+3.3% upside

Dividends

By Dow Jones

Next Earnings

28 lip 2025

Market Stats

By TradingEconomics

Market Cap

-1.1B

14B

Previous open

62.21

Previous close

64.32

News Sentiment

By Acuity

24%

76%

56 / 380 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

Hologic Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

27 maj 2025, 18:46 UTC

Major Market Movers
Acquisitions, Mergers, Takeovers

Hologic Shares Up Following Report of Buyout Offer From TPG, Blackstone

27 maj 2025, 20:07 UTC

Acquisitions, Mergers, Takeovers

Hologic Stock Is Surging. Why Shares of the MedTech Company Are Up 14%. -- Barrons.com

27 maj 2025, 19:06 UTC

Acquisitions, Mergers, Takeovers

Hologic Stock Is Surging. Why Shares of the MedTech Company Are Up 14%. -- Barrons.com

27 maj 2025, 18:26 UTC

Acquisitions, Mergers, Takeovers

Hologic Stock Is Surging. Why Shares of the MedTech Company Are Up 19%. -- Barrons.com

Peer Comparison

Price change

Hologic Inc Forecast

Price Target

By TipRanks

3.3% upside

12 Months Forecast

Average 66.45 USD  3.3%

High 71 USD

Low 60 USD

Based on 14 Wall Street analysts offering 12 month price targets forHologic Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

14 ratings

5

Buy

9

Hold

0

Sell

Technical Score

By Trading Central

52.69 / 58.605Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Weak Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

56 / 380 Ranking in Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Hologic Inc

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, and specimen radiology solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. The company was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.